Search

everythinglearnresearchcommunity

for

Search:↓

PBX1 helps hair stem cells grow and change by turning on certain cell signals and preventing cell death, which may be useful for hair regrowth treatments.

PRP is useful for hair restoration.

A specific gene variant is linked to severe insulin resistance and hormone imbalance in a teenage girl.

Repetin is a protein involved in skin and hair development, binding calcium and compensating for other proteins when needed.

PRP treatments for hair loss need standard protocols to be reliable.

SP1 promotes and KROX20 inhibits hair cell growth by affecting the CUX1 gene.

Using PDRN injections and RF treatments improved revision nose surgery results without major side effects.

A mutation in the EDNRA gene causes Oro-Oto-Cardiac syndrome, affecting face and heart development.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Progesterone reduces anxiety without needing progesterone receptors.

Proretinal nanoparticles are a safe and effective way to deliver retinal to the skin.

PRC1 influences skin stem cell development by both turning genes on and off, affecting hair growth and skin cell types.

Epiprofin suppresses parathyroid hormone gene activity, helping regulate calcium levels and could be a treatment target for hyperparathyroidism.

PRAME helps distinguish between benign and malignant skin cells in most cases.

PRP injections improve voice quality and are safe for treating vocal fold scars.

Different cells affect hair follicle blood vessels, endothelial cells react differently to inflammation and oxidized fats, and prasugrel better protects heart vessels during a procedure than clopidogrel.

A position effect on the TRPS1 gene causes excessive hair growth in humans and mice.

RALF22 is essential for root hair growth in response to fungal emissions in Arabidopsis.

Most patients use PRP for hair loss and facial rejuvenation with minor side effects.

A higher genetic risk score increases the chance of getting benign prostatic hyperplasia and affects treatment outcomes in Han Chinese men.

L-PRP and P-PRP reduced endometriosis in rats, but not significantly more than saline.

EF and PXE not closely related.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

Injecting patients' own PRP into their thyroid improved thyroid function and symptoms in most hypothyroidism cases.

Polygenic risk scores can predict the risk and outcomes of benign prostatic hyperplasia.

L-PRF is effective for bone regeneration in the mouth.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Platelet Rich Plasma (PRP) shows promise for tissue repair and immune response, but more research is needed to fully understand it and optimize its use.